CLINICAL DECISION SUPPORT SYSTEM
PRECISE-CDSS
Designed to bridge the gap between complex genomic data and real-time clinical decision-making. Find out more on why PRECISE-CDSS matters.
Precision starts here
pioneering and leading clinical- accredited genome-wide pharmacogenomics
PRECISE Infrastructure closes the PGx adoption gap, giving providers end-to-end confidence by uniting clinical-accredited reports, aligned to globally recognised regulatory bodies, seamless CDSS integration, workflow-native decision support, education and support from pharmacogenomics-certified professionals — making personalised prescribing implementable, trusted, actionable and practical.
Commonly known as Plavix
Common medication for blood thinner
Select a medication and profile to see how DNA impact treatment.
Disclaimer: The following simulation is not the actual result of the report as it is serves as an example for education purposes.

PRECISE Clinical-Accredited Reports aligned with recognised international regulatory bodies and professional guidelines including the FDA, CPIC, DPWG, NCCN, NICE, IWPC, and the Association of Molecular Pathology’s best practice standards — to ensure every recommendation is clinically evidence-based and trustworthy.

Straightforward Interpretation Steps that turn PRECISE Reports into clear, actionable gene-drug interaction guidance, with explicit clinical recommendations and/or clinical evidence.
Embed PGx data directly into clinician's workflows
Integrated fully with real-time data
PRECISE-CDSS Digital Tools embed PGx data directly into clinicians’ workflows by integrating with the Doctor Portal, EHR and/or EMR systems.
Designed to bridge the gap between complex genomic data and real-time clinical decision-making. Find out more on why PRECISE-CDSS matters.
Dedicated In-House Team of Pharmacogenomics-Certified Professionals is always ready to consult on test results, help interpret complex gene-drug interactions, and devise proposed optimized therapy plans—providing healthcare providers with the confidence to apply genetic insights to patient care.
We champion education through PRECISE-Edu: Clinical Implementation of PGx, an accreditation course developed in collaboration with academic and industry partners. This program trains doctors, pharmacists, and other healthcare professionals in the practical aspects of clinical pharmacogenomics. Participants learn how to incorporate PGx into clinical practice, interpret reports, and implement gene-guided therapies both effectively and confidently. By certifying professionals in PGx, we’re building a nationwide and Southeast Asia–wide network of “PGx-ready” doctors and healthcare providers committed to precision medicine.
Covers more than 20 therapeutic areas (> 1,000 genes and > 500 medications), including:
~ Suitable for Reactive and Pre-emptive Test ~
From Single-Gene Test, Small-Panels to Comprehensive Genome-Wide Panels,
covering major drug-gene interactions across virtually all medical specialities.
From Point-of-Care Rapid Probe-based Assays to
Cutting-Edge Long-Read Platforms,
delivering fast turnaround within hours to enable rapid clinical decisions and state-of-the-art accuracy in complex genes.
PRECISE Advisory Board brings together a cadre of acclaimed experts, including Pathologist, Clinical Oncologist, Medical Director, Neurologist, Pharmacogenomics-Certified Professionals, Clinical Geneticist, Head of Genetic Unit, Top Scientist, Council for Malaysian Allied Health Professions, Chairman of Malaysia Stroke Council, President of Precision Medicine and Scientific Wellness, Vice-President of Federation of Asian Pharmaceutical Associations, Principal Investigator for Pharmacogenomics Implementation: Precision Medicine Initiatives, Certified-Diabetes Educator.
Digital Assistant
Typically replies within business hours
I am interested in your services.
WhatsApp Us
©Precision Diagnostics | Privacy Policy